Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL712661

O=C(O)C(F)(F)F.c1ccc(CCOc2cc(OCc3ccccc3)cc(-c3nc4cccnc4[nH]3)c2)cc1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.41
PRMT5 O14744 3/20 0.39
FFAR1 O14842 1/20 0.39
SCD O00767 1/20 0.38
DHODH Q02127 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP3A4 P08684 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL712377 0.94 CHEK2 (0.45) CHEK2PRMT5SCDDHODHMEN1
SCHEMBL10206644 0.91 PRMT5 (0.46) CHEK2PRMT5DHODHPDE4APDE4B
Trifluoroacetic Acid SCHEMBL711040 0.90 DHODH (0.45) CHEK2PRMT5DHODHMEN1KMT2A
Trifluoroacetic Acid SCHEMBL720615 0.89 GCK (0.45) PDE4APDE4BPDE4CPDE4DKMT2A
Trifluoroacetic Acid SCHEMBL718789 0.89 PDE4A (0.35) CHEK2FFAR1PDE4APDE4BPDE4C
Trifluoroacetic Acid SCHEMBL713011 0.87 GCK (0.44) CHEK2PRMT5SCDDHODH
Trifluoroacetic Acid SCHEMBL711105 0.87 CYP1A1 (0.41) CHEK2PRMT5SCDDHODH
Trifluoroacetic Acid SCHEMBL711953 0.86 CHEK2 (0.40) CHEK2PRMT5FFAR1SCDDHODH
Trifluoroacetic Acid SCHEMBL710853 0.86 PPARG (0.39) CHEK2PRMT5SCDDHODHCYP3A4
Trifluoroacetic Acid SCHEMBL709196 0.86 FFAR1 (0.42) CHEK2PRMT5FFAR1DHODHMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940837-B1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2012-11-07 EP disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 US disclosed
EP-1940837-A2 IMIDAZOPYRIDINE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2008-07-09 EP disclosed
WO-2007028135-A2 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK CHEK2 1189/4885PRMT5 2373/4885FFAR1 3394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.